	US 11,730,832 B2
	Plastic containers
Karina Martha Langseth-Manrique, Oslo (NO); Arne Wang Aabye, Oslo (NO); Harald Laugen, Oslo (NO); Eva Krog Tamnes, Oslo (NO); and Borge Mathisen, Oslo (NO)
Assigned to GE HEALTHCARE AS, Oslo (NO)
Filed by GE Healthcare AS, Oslo (NO)
Filed on Oct. 26, 2020, as Appl. No. 17/79,724.
Application 17/079,724 is a division of application No. 15/877,095, filed on Jan. 22, 2018, granted, now 10,842,888.
Claims priority of provisional application 62/448,698, filed on Jan. 20, 2017.
Claims priority of application No. 1703227 (GB), filed on Feb. 28, 2017.
Prior Publication US 2021/0069355 A1, Mar. 11, 2021
This patent is subject to a terminal disclaimer.
Int. Cl. A61K 49/10 (2006.01); B65B 3/00 (2006.01); A61J 1/10 (2006.01); A61J 1/05 (2006.01); A61B 5/055 (2006.01)

CPC A61K 49/108 (2013.01) [A61J 1/05 (2013.01); B65B 3/003 (2013.01); A61B 5/055 (2013.01); A61J 1/10 (2013.01)]

15 Claims

1. A method for providing a gadolinium-DOTA solution wherein said method comprises:

(i) manufacturing a batch of said gadolinium-DOTA solution; and,

(ii) dispensing said gadolinium-DOTA solution into a pharmaceutical-grade cyclic olefin plastic container, wherein said container is a syringe;

wherein said syringe comprises oxygen in the headspace of the syringe and is sufficiently transparent to permit visual verification of the contents of the syringe.